(Open access funding provided by Semmelweis University)
(ÚNKP-21-5)
(EFOP-1.8.0-VEKOP-17-2017-00001)
(2018-1.2.1-NKP-2018-00005) Támogató: NKFIH
Establishing the Hungarian Center of Excellence for Molecular Medicine in partnership
with EMBL(739593) Támogató: Horizon 2020
(TKP-BIO- Imaging-2020-4.1.1-TKP2020)
(2020.1.16-jövő-2021-00013)
(TKP2021-EGA-31)
(2020-1.1.2-PIACI-KFI-2020-00021)
Szakterületek:
Tudomány
The important roles of bacterial outer membrane vesicles (OMVs) in various diseases
and their emergence as a promising platform for vaccine development and targeted drug
delivery necessitates the development of imaging techniques suitable for quantifying
their biodistribution with high precision. To address this requirement, we aimed to
develop an OMV specific radiolabeling technique for positron emission tomography (PET).
A novel bacterial strain ( E. coli BL21(DE3) ΔnlpI, ΔlpxM ) was created for efficient
OMV production, and OMVs were characterized using various methods. SpyCatcher was
anchored to the OMV outer membrane using autotransporter-based surface display systems.
Synthetic SpyTag-NODAGA conjugates were tested for OMV surface binding and 64 Cu labeling
efficiency. The final labeling protocol shows a radiochemical purity of 100% with
a ~ 29% radiolabeling efficiency and excellent serum stability. The in vivo biodistribution
of OMVs labeled with 64 Cu was determined in mice using PET/MRI imaging which revealed
that the biodistribution of radiolabeled OMVs in mice is characteristic of previously
reported data with the highest organ uptakes corresponding to the liver and spleen
3, 6, and 12 h following intravenous administration. This novel method can serve as
a basis for a general OMV radiolabeling scheme and could be used in vaccine- and drug-carrier
development based on bioengineered OMVs.